0

Journal Articles

in Journalology/Peer Review/Authorship
 21-40 of 68 Articles
Editorial |  February 09, 2011
Thank You—JAMA Authors and Peer Reviewers
Catherine D. DeAngelis, MD, MPH; Phil B. Fontanarosa, MD, MBA
JAMA. 2011;305(6):608. doi:10.1001/jama.2011.102.
Research Letters |  September 15, 2010 FREE
Association of Institutional Financial Support of a Core Teaching Faculty With Educational Productivity
Michael T. Fitch, MD, PhD; Hal H. Atkinson, MD, MS; Cynthia A. Burns, MD; et al.
JAMA. 2010;304(11):1169-1170. doi:10.1001/jama.2010.1317.
Commentary |  August 04, 2010
Large-Scale “Expert” Mortality Surveys in Conflicts—Concerns and Recommendations
Paul B. Spiegel, MD, MPH; Courtland Robinson, PhD
JAMA. 2010;304(5):567-568. doi:10.1001/jama.2010.1094.
Letters |  July 14, 2010
Bias and Trials Stopped Early for Benefit—Reply
Gordon H. Guyatt, MD, MSc; Dirk Bassler, MD, MSc; Victor M. Montori, MD, MSc
JAMA. 2010;304(2):156-159. doi:10.1001/jama.2010.934.
Original Contribution |  May 26, 2010 FREE
Reporting and Interpretation of Randomized Controlled Trials With Statistically Nonsignificant Results for Primary Outcomes
Isabelle Boutron, MD, PhD; Susan Dutton, MSc; Philippe Ravaud, MD, PhD; et al.
JAMA. 2010;303(20):2058-2064. doi:10.1001/jama.2010.651.
INCLUDES: , Supplemental Content
Editorial |  February 24, 2010
To JAMA Peer Reviewers and Authors—Thank You
Phil B. Fontanarosa, MD, MBA; Catherine D. DeAngelis, MD, MPH
JAMA. 2010;303(8):780. doi:10.1001/jama.2010.174.
Editorial |  September 16, 2009
Mortality in Celiac Disease, Intestinal Inflammation, and Gluten Sensitivity
Peter H. R. Green, MD
JAMA. 2009;302(11):1225-1226. doi:10.1001/jama.281.24.2344.
Brief Report |  September 09, 2009 FREE
Comparisons of Citations in Web of Science, Scopus, and Google Scholar for Articles Published in General Medical Journals
Abhaya V. Kulkarni, MD, PhD; Brittany Aziz, BHSc; Iffat Shams, MPH; et al.
JAMA. 2009;302(10):1092-1096. doi:10.1001/jama.2009.1307.
Commentary |  September 09, 2009 FREE
The Journal Impact Factor Denominator:  Defining Citable (Counted) Items
Marie E. McVeigh, MS; Stephen J. Mann
JAMA. 2009;302(10):1107-1109. doi:10.1001/jama.2009.1301.
Original Contribution |  September 02, 2009 FREE
Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials
Sylvain Mathieu, MD; Isabelle Boutron, MD, PhD; David Moher, PhD; et al.
JAMA. 2009;302(9):977-984. doi:10.1001/jama.2009.1242.
Review |  August 05, 2009 FREE
Sexual Abuse and Lifetime Diagnosis of Somatic Disorders:  A Systematic Review and Meta-analysis
Molly L. Paras, BS; Mohammad Hassan Murad, MD; Laura P. Chen, BS; et al.
JAMA. 2009;302(5):550-561. doi:10.1001/jama.2009.1091.
INCLUDES: CME
Commentary |  July 08, 2009
The Need for Improved Access to FDA Reviews
Alec B. O’Connor, MD, MPH
JAMA. 2009;302(2):191-193. doi:10.1001/jama.2009.973.
JAMA Classics |  April 01, 2009 FREE
The Roman Article: Read It Again—in the Same Journal
Catherine D. DeAngelis, MD, MPH
JAMA. 2009;301(13):1382-1383. doi:10.1001/jama.2009.401.
INCLUDES: , Supplemental Content
Editorial |  February 25, 2009
Thank You, JAMA Peer Reviewers and Authors
Phil B. Fontanarosa, MD, MBA; Catherine D. DeAngelis, MD, MPH
JAMA. 2009;301(8):870. doi:10.1001/jama.2009.206.
Commentary |  August 27, 2008
Opportunities for Enhancing the FDA Guidance on Pharmacovigilance
Bruce M. Psaty, MD, PhD; Jan P. Vandenbroucke, MD, PhD
JAMA. 2008;300(8):952-954. doi:10.1001/jama.300.8.952.
Commentary |  April 23, 2008
FDA Guidance on Off-Label Promotion and the State of the Literature From Sponsors
JAMA. 2008;299(16):1949-1951. doi:10.1001/jama.299.16.1949.
Editorial |  February 20, 2008
To JAMA Peer Reviewers and Authors—Thank You
Phil B. Fontanarosa, MD, MBA; Catherine D. DeAngelis, MD, MPH
JAMA. 2008;299(7):821. doi:10.1001/jama.299.7.821.
Editorial |  January 02, 2008
Publication of Clinical Trials in JAMA:  Information for Authors
Phil B. Fontanarosa, MD, MBA; Catherine D. DeAngelis, MD, MPH
JAMA. 2008;299(1):95-96. doi:10.1001/jama.2007.28.
Medical News and Perspectives |  April 18, 2007
New European Funding Agency Backs “Blue-Skies” Research
JAMA. 2007;297(15):1644. doi:10.1001/jama.297.15.1644.
Editorial |  February 28, 2007
Thank You to JAMA Peer Reviewers and Authors
Phil B. Fontanarosa, MD, MBA; Catherine D. DeAngelis, MD, MPH
JAMA. 2007;297(8):875. doi:10.1001/jama.297.8.875.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Time to Publication Among Completed Clinical Trials
Joseph S. Ross, MD, MHS; Marian Mocanu, MD; Julianna F. Lampropulos, MD; et al.
JAMA Internal Medicine
Viewpoint  |  April 22, 2013
Assessing Research Results in the Medical Literature:  Trust but Verify
Robert M. Califf, MD; Jonathan McCall, MS; Robert A. Harrington, MD
JAMA Internal Medicine
Invited Commentary  |  March 25, 2013
Biomarkers in Cardiovascular Medicine:  The Shame of Publication Bias
Comment on “Bias in Associations of Emerging Biomarkers With Cardiovascular Disease”
Steven E. Nissen, MD
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems